EMSLR and urinary bladder carcinoma: Furthermore, the CRISPR/Cas9 system will be utilized to convert the genotype of lncRNA BCCE4 rs62483508 in EJ and J82 cell lines, thereby directly confirming the effect of the rs62483508 genotype on the bladder cancer cell malignant phenotype.